Search - tctmd.com

Displaying 221 - 240 of 287

Sort: Relevancy | Date

News Conference News ESC 2018

SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions

Shelley Wood

August 31, 2018

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Caitlin E. Cox

July 30, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2018

Caitlin E. Cox

June 01, 2018

News Conference News EuroPCR 2018

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

Caitlin E. Cox

May 30, 2018

News Conference News EuroPCR 2018

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Caitlin E. Cox

May 25, 2018

News Daily News

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

L.A. McKeown

May 15, 2018

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Caitlin E. Cox

May 02, 2018

News Daily News

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

Caitlin E. Cox

April 12, 2018

News Daily News

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Michael O'Riordan

February 20, 2018

News Daily News

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

L.A. McKeown

January 02, 2018

Presentation TCT 2017

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Presenter: Azeem Latib, Dean J. Kereiakes

October 31, 2017

Presentation TCT 2017

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Presenter: Azeem Latib, Bernard R. Chevalier

October 31, 2017

Presentation TCT 2017

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

Presenter: Azeem Latib, Manel Sabate

October 31, 2017

Presentation TCT 2017

New Insights From AIDA: Subgroups and Predictors of Adverse Events

Presenter: Azeem Latib, Joanna J. Wykrzykowska

October 31, 2017

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Todd Neale

October 30, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

Shelley Wood

October 29, 2017

News Daily News

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

Todd Neale

October 23, 2017

News Daily News

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

Todd Neale

October 02, 2017

Advertisement

SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

TCTMD’s Top 10 Most Popular Stories for May 2018

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

New Insights From AIDA: Subgroups and Predictors of Adverse Events

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

TCTMD’s Top 10 Most Popular Stories for October 2017

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content